🔴 Senti Biosciences is trading 7.38% down today in after-hours trading — No clear company-specific catalyst identified

Senti Biosciences is trading 7.38% down at $0.35 after no clear company-specific catalyst was identified for August 24, 2026.

• Latest results, released August 14, showed a $12.75 million second-quarter net loss and $6.5 million in cash as of June 30.
• The company reported substantial going-concern concerns.
• The broader market was largely mixed rather than sharply risk-off; the decline remains unexplained and may reflect continued pressure following recent earnings and liquidity concerns.